dexloxiglumide has been researched along with Muscle Contraction in 2 studies
*Muscle Contraction: A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments. [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barrett, TD; Breitenbucher, JG; Figueroa, K; Freedman, JM; Lagaud, G; Li, L; McClure, K; Moreno, V; Morton, MF; Prendergast, CE; Pyati, J; Rizzolio, M; Shankley, NP; Wu, X; Yan, W | 1 |
Caruso, ML; Guerra, V; Lorusso, D; Makovec, F; Maselli, MA; Mennuni, L; Pezzolla, F; Piepoli, AL | 1 |
2 other study(ies) available for dexloxiglumide and Muscle Contraction
Article | Year |
---|---|
3-[5-(3,4-Dichloro-phenyl)-1-(4-methoxy-phenyl)-1H-pyrazol-3-yl]-2-m-tolyl-propionate (JNJ-17156516), a novel, potent, and selective cholecystokinin 1 receptor antagonist: in vitro and in vivo pharmacological comparison with dexloxiglumide.
Topics: Animals; Cricetinae; Dogs; Dose-Response Relationship, Drug; Gallbladder; Guinea Pigs; Humans; In Vitro Techniques; Male; Muscle Contraction; Pentanoic Acids; Phenylpropionates; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin A | 2007 |
Effect of three nonpeptide cholecystokinin antagonists on human isolated gallbladder.
Topics: Cholecystokinin; Gallbladder; Hormone Antagonists; Humans; In Vitro Techniques; Muscle Contraction; Muscle, Smooth; Pentanoic Acids; Proglumide | 2001 |